ResMed reported $326.37M in EBITDA for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ansell ANN:AU USD 126.7M 52M
Cochlear COH:AU AUD 232.3M 19.3M
Estia Health EHE:AU AUD 44.03M 26.34M
Fisher & Paykel Healthcare FPH:AU NZD 169.5M 76.6M
Healius Ltd HLS:AU AUD 176.2M 82.5M
Integral Diagnostics Ltd IDX:AU AUD 38.71M 1.9M
Mayne Pharma MYX:AU AUD -78259000 83.25M
Nanosonics Ltd NAN:AU AUD 14.1M 12.8M
Polynovo Ltd PNV:AU AUD -2536020 1.89M
Ramsay Health Care RHC:AU AUD 760.9M 176.9M
Regis Healthcare REG:AU AUD 60.37M 27.42M
ResMed RMD:AU USD 326.37M 31.7M
Sigma Healthcare Ltd SIG:AU AUD 28.59M 5.82M
Sonic Healthcare SHL:AU AUD 924.61M 367.46M
Telix Pharmaceuticals Ltd TLX:AU AUD -18962000 47.51M